These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32670851)

  • 1. Medical approach to the treatment of feline injection site sarcoma with masitinib: a case report.
    Ledoux JM; Brun P; Chapuis T; Dumas P; Guillotin J
    Vet Med (Auckl); 2014; 5():109-113. PubMed ID: 32670851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative effects of masitinib and imatinib against canine oral fibrosarcoma in vitro.
    Milovancev M; Helfand SC; Marley K; Goodall CP; Löhr CV; Bracha S
    BMC Vet Res; 2016 Jun; 12():85. PubMed ID: 27259510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Scoping Review on Tyrosine Kinase Inhibitors in Cats: Current Evidence and Future Directions.
    Žagar Ž; Schmidt JM
    Animals (Basel); 2023 Sep; 13(19):. PubMed ID: 37835664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imatinib mesylate inhibits platelet-derived growth factor activity and increases chemosensitivity in feline vaccine-associated sarcoma.
    Katayama R; Huelsmeyer MK; Marr AK; Kurzman ID; Thamm DH; Vail DM
    Cancer Chemother Pharmacol; 2004 Jul; 54(1):25-33. PubMed ID: 15108021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Masitinib demonstrates anti-proliferative and pro-apoptotic activity in primary and metastatic feline injection-site sarcoma cells.
    Lawrence J; Saba C; Gogal R; Lamberth O; Vandenplas ML; Hurley DJ; Dubreuil P; Hermine O; Dobbin K; Turek M
    Vet Comp Oncol; 2012 Jun; 10(2):143-54. PubMed ID: 22236016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tyrosine kinase inhibitor toceranib in feline injection site sarcoma: efficacy and side effects.
    Holtermann N; Kiupel M; Hirschberger J
    Vet Comp Oncol; 2017 Jun; 15(2):632-640. PubMed ID: 26762970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Masitinib (AB1010), from canine tumor model to human clinical development: where we are?
    Marech I; Patruno R; Zizzo N; Gadaleta C; Introna M; Zito AF; Gadaleta CD; Ranieri G
    Crit Rev Oncol Hematol; 2014 Jul; 91(1):98-111. PubMed ID: 24405856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Masitinib mesylate does not enhance sensitivity to radiation in three feline injection-site sarcoma cell lines under normal growth conditions.
    Turek M; Gogal R; Saba C; Vandenplas ML; Hill J; Feldhausser B; Lawrence J
    Res Vet Sci; 2014 Apr; 96(2):304-7. PubMed ID: 24602916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin Conjugated to Glutathione Stabilized Gold Nanoparticles (Au-GSH-Dox) as an Effective Therapeutic Agent for Feline Injection-Site Sarcomas-Chick Embryo Chorioallantoic Membrane Study.
    Zabielska-Koczywąs K; Dolka I; Król M; Żbikowski A; Lewandowski W; Mieczkowski J; Wójcik M; Lechowski R
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28208720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological effect of tyrosine kinase inhibitors on three canine mast cell tumor cell lines with various KIT statuses.
    Takeuchi Y; Fujino Y; Fukushima K; Watanabe M; Nakagawa T; Ohno K; Sasaki N; Sugano S; Tsujimoto H
    J Vet Pharmacol Ther; 2012 Feb; 35(1):97-104. PubMed ID: 21480930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
    Croom KF; Perry CM
    Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of tyrosine kinases and use of imatinib in small animal practice.
    Bonkobara M
    Vet J; 2015 Aug; 205(2):180-8. PubMed ID: 25592261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of masitinib in cats.
    Bellamy F; Bader T; Moussy A; Hermine O
    Vet Res Commun; 2009 Dec; 33(8):831-7. PubMed ID: 19533403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.
    Hayashi Y; Bardsley MR; Toyomasu Y; Milosavljevic S; Gajdos GB; Choi KM; Reid-Lombardo KM; Kendrick ML; Bingener-Casey J; Tang CM; Sicklick JK; Gibbons SJ; Farrugia G; Taguchi T; Gupta A; Rubin BP; Fletcher JA; Ramachandran A; Ordog T
    Gastroenterology; 2015 Aug; 149(2):420-32.e16. PubMed ID: 25865047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidating the transcriptional program of feline injection-site sarcoma using a cross-species mRNA-sequencing approach.
    Wei Q; Ramsey SA; Larson MK; Berlow NE; Ochola D; Shiprack C; Kashyap A; Séguin B; Keller C; Löhr CV
    BMC Cancer; 2019 Apr; 19(1):311. PubMed ID: 30947707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of masitinib mesylate in healthy cats.
    Daly M; Sheppard S; Cohen N; Nabity M; Moussy A; Hermine O; Wilson H
    J Vet Intern Med; 2011; 25(2):297-302. PubMed ID: 21314730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical excision with five-centimeter margins for treatment of feline injection-site sarcomas: 91 cases (1998-2002).
    Phelps HA; Kuntz CA; Milner RJ; Powers BE; Bacon NJ
    J Am Vet Med Assoc; 2011 Jul; 239(1):97-106. PubMed ID: 21718202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics.
    Humbert M; de Blay F; Garcia G; Prud'homme A; Leroyer C; Magnan A; Tunon-de-Lara JM; Pison C; Aubier M; Charpin D; Vachier I; Purohit A; Gineste P; Bader T; Moussy A; Hermine O; Chanez P
    Allergy; 2009 Aug; 64(8):1194-201. PubMed ID: 19614621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential properties of current tyrosine kinase inhibitors in gastrointestinal stromal tumors.
    Demetri GD
    Semin Oncol; 2011 Apr; 38 Suppl 1():S10-9. PubMed ID: 21419931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tyrosine kinase inhibitor masitinib blunts airway inflammation and improves associated lung mechanics in a feline model of chronic allergic asthma.
    Lee-Fowler TM; Guntur V; Dodam J; Cohn LA; DeClue AE; Reinero CR
    Int Arch Allergy Immunol; 2012; 158(4):369-74. PubMed ID: 22487554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.